These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 36754082

  • 1. Clinical Course of Very Early-Onset Inflammatory Bowel Disease.
    Cucinotta U, Arrigo S, Dipasquale V, Gramaglia SMC, Laganà F, Romano C, Gandullia P.
    J Pediatr Gastroenterol Nutr; 2023 May 01; 76(5):590-595. PubMed ID: 36754082
    [Abstract] [Full Text] [Related]

  • 2. Very-early-onset inflammatory bowel disease versus late-onset inflammatory bowel disease in relation to clinical phenotype: A cross-sectional study.
    Mansour HH, Seddek SS, Meguid MEAEL, Eskander AE, Galal ST.
    Indian J Gastroenterol; 2023 Apr 01; 42(2):185-191. PubMed ID: 37166697
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Phenotypic and genotypic characterization of inflammatory bowel disease in children under six years of age in China.
    Fang YH, Luo YY, Yu JD, Lou JG, Chen J.
    World J Gastroenterol; 2018 Mar 07; 24(9):1035-1045. PubMed ID: 29531467
    [Abstract] [Full Text] [Related]

  • 5. Application of a pattern-based approach to histological diagnosis in very early onset IBD (VEO-IBD) in a multicentric cohort of children with emphasis on monogenic disease with IBD-like morphology.
    Parente P, Macciomei MC, Buccoliero AM, Santoro L, Cafferata B, Bifano D, Ferro J, Vanoli A, Fassan M, Angerilli V, Alaggio R, Mastracci L, D'Armiento M, Grillo F, Francalanci P.
    Histopathology; 2024 Feb 07; 84(3):440-450. PubMed ID: 37903647
    [Abstract] [Full Text] [Related]

  • 6. Comprehensive mutation screening for 10 genes in Chinese patients suffering very early onset inflammatory bowel disease.
    Xiao Y, Wang XQ, Yu Y, Guo Y, Xu X, Gong L, Zhou T, Li XQ, Xu CD.
    World J Gastroenterol; 2016 Jun 28; 22(24):5578-88. PubMed ID: 27350736
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of infliximab in very early onset inflammatory bowel disease: a national comparative retrospective study.
    Bramuzzo M, Arrigo S, Romano C, Filardi MC, Lionetti P, Agrusti A, Dipasquale V, Paci M, Zuin G, Aloi M, Strisciuglio C, Miele E, Pastore M, Martelossi S, Alvisi P, SIGENP IBD Working Group.
    United European Gastroenterol J; 2019 Jul 28; 7(6):759-766. PubMed ID: 31316780
    [Abstract] [Full Text] [Related]

  • 8. Phenotype and outcomes of very early onset and early onset inflammatory bowel diseases in a Montreal pediatric cohort.
    Chapuy L, Leduc B, Godin D, Damphousse A, Patey N, Dal Soglio D, Jantchou P, Deslandres C.
    Front Pediatr; 2023 Jul 28; 11():1157025. PubMed ID: 37082701
    [Abstract] [Full Text] [Related]

  • 9. Psoriasis and Psoriasiform Eruptions in Pediatric Patients with Inflammatory Bowel Disease Treated with Anti-Tumor Necrosis Factor Alpha Agents.
    Eickstaedt JB, Killpack L, Tung J, Davis D, Hand JL, Tollefson MM.
    Pediatr Dermatol; 2017 May 28; 34(3):253-260. PubMed ID: 28211161
    [Abstract] [Full Text] [Related]

  • 10. [Pediatric very early onset inflammatory bowel disease: Role of pathology].
    Drabent P, Berrebi D.
    Ann Pathol; 2023 Jun 28; 43(3):202-212. PubMed ID: 36863899
    [Abstract] [Full Text] [Related]

  • 11. The Unique Disease Course of Children with Very Early onset-Inflammatory Bowel Disease.
    Kelsen JR, Conrad MA, Dawany N, Patel T, Shraim R, Merz A, Maurer K, Sullivan KE, Devoto M.
    Inflamm Bowel Dis; 2020 May 12; 26(6):909-918. PubMed ID: 31560377
    [Abstract] [Full Text] [Related]

  • 12. A Pattern-based Pathology Approach to Very Early-onset Inflammatory Bowel Disease: Thinking Beyond Crohn Disease and Ulcerative Colitis.
    Wilkins BJ, Kelsen JR, Conrad MA.
    Adv Anat Pathol; 2022 Jan 01; 29(1):62-70. PubMed ID: 34813528
    [Abstract] [Full Text] [Related]

  • 13. Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease: Prevalence, Presentation, and Anti-TNF Treatment.
    Greuter T, Bertoldo F, Rechner R, Straumann A, Biedermann L, Zeitz J, Misselwitz B, Scharl M, Rogler G, Safroneeva E, Ali RAR, Braegger C, Heyland K, Mueller P, Nydegger A, Petit LM, Schibli S, Furlano RI, Spalinger J, Schäppi M, Zamora S, Froehlich F, Herzog D, Schoepfer AM, Vavricka SR, Swiss IBD Cohort Study Group.
    J Pediatr Gastroenterol Nutr; 2017 Aug 01; 65(2):200-206. PubMed ID: 27801751
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic management of inflammatory bowel disease in real-life practice in the current era of anti-TNF agents: analysis of the French administrative health databases 2009-2014.
    Kirchgesner J, Lemaitre M, Rudnichi A, Racine A, Zureik M, Carbonnel F, Dray-Spira R.
    Aliment Pharmacol Ther; 2017 Jan 01; 45(1):37-49. PubMed ID: 27781286
    [Abstract] [Full Text] [Related]

  • 15. Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies.
    Ouahed J, Spencer E, Kotlarz D, Shouval DS, Kowalik M, Peng K, Field M, Grushkin-Lerner L, Pai SY, Bousvaros A, Cho J, Argmann C, Schadt E, Mcgovern DPB, Mokry M, Nieuwenhuis E, Clevers H, Powrie F, Uhlig H, Klein C, Muise A, Dubinsky M, Snapper SB.
    Inflamm Bowel Dis; 2020 May 12; 26(6):820-842. PubMed ID: 31833544
    [Abstract] [Full Text] [Related]

  • 16. Treatment patterns of anti-tumour necrosis factor-alpha and prognosis of paediatric and adult-onset inflammatory bowel disease in Korea: a nationwide population-based study.
    Choe YJ, Han K, Shim JO.
    Aliment Pharmacol Ther; 2022 Sep 12; 56(6):980-988. PubMed ID: 35791668
    [Abstract] [Full Text] [Related]

  • 17. Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis.
    Billioud V, Ford AC, Tedesco ED, Colombel JF, Roblin X, Peyrin-Biroulet L.
    J Crohns Colitis; 2013 Dec 12; 7(11):853-67. PubMed ID: 23523418
    [Abstract] [Full Text] [Related]

  • 18. Infliximab for very early-onset inflammatory bowel disease: A tertiary center experience in Japan.
    Takeuchi I, Kaburaki Y, Arai K, Shimizu H, Hirano Y, Nagata S, Shimizu T.
    J Gastroenterol Hepatol; 2020 Apr 12; 35(4):593-600. PubMed ID: 31425641
    [Abstract] [Full Text] [Related]

  • 19. Higher Prevalence of Monogenic Cause Among Very Early Onset Inflammatory Bowel Disease in Children: Experience From a Tertiary Care Center From Northern India.
    Poddar U, Aggarwal A, Jayalakshmi K, Sarma MS, Srivastava A, Rawat A, Yachha SK.
    Inflamm Bowel Dis; 2023 Oct 03; 29(10):1572-1578. PubMed ID: 36594920
    [Abstract] [Full Text] [Related]

  • 20. Clinical Phenotype and Disease Course of Inflammatory Bowel Disease: A Comparison Between Sporadic and Familial Cases.
    Saberzadeh-Ardestani B, Anushiravani A, Mansour-Ghanaei F, Fakheri H, Vahedi H, Sheikhesmaeili F, Yazdanbod A, Moosavy SH, Vosoghinia H, Maleki I, Nasseri-Moghaddam S, Khosravi B, Malekzadeh M, Kasaeian A, Alatab S, Sadeghi A, Kolahdoozan S, Rayatpisheh M, Sima AR, Malekzadeh R.
    Inflamm Bowel Dis; 2022 Jul 01; 28(7):1004-1011. PubMed ID: 34417824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.